11 September 2024
The Russian Ministry of Health has introduced amendments for the second reading of the bill that regulates the biologically active additives (BAA) market. According to these changes, only those BAA’s whose effectiveness has been confirmed by research will be allowed for sale. Expert organizations will evaluate the results of these studies to ensure the supplements’ effects on the body before they are released to the market.
The bill, put forward by the government in May 2023, aims to establish a registry of approved alternative treatments that doctors can suggest to their patients. Manufacturers must demonstrate that BAA’s are crafted with secure and superior raw materials to secure their inclusion in this list.
The explanatory note to the bill emphasizes that this approach is aimed at protecting the health of citizens, since many take BAA’s without supervision, prescribing them to themselves. In early July, the State Duma approved these approaches in the first reading. The Ministry of Health presented its proposals for the second reading, which it sent to Deputy Prime Minister Tatyana Golikova.
PrintNovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
The Ministry of Economic Development predicts a 33.1% increase in medical production by 2027
04 October 2024
Deputy Prime Minister: “Russia helps CIS and African countries with monkeypox diagnostics”
04 October 2024
Optimising wet granulation manufacturing with advanced technologies
03 October 2024
First-in-class therapy approved for schizophrenia
03 October 2024